Sobo-Vujanovic et al. have shown that sTNFα blockade with a dominant negative protein specific for sTNFα, INB03, or TNFR1 deletion not only prevented carcinogenesis but also decreased tumor growth and increased survival of methylcholanthrene-injected mice (71). This evidence concerns the gene TNFRSF1A and neoplasm.